GOLDEN, Colo., May 1, 2012 (GLOBE NEWSWIRE) -- Vitro Diagnostics, Inc. (OTCQB:VODG), dba Vitro Biopharma, today responded to recent market activity concerning trading of VODG securities. The Company has become aware that an unaffiliated third party acting independently of the Company and without the prior knowledge of the Company released a promotional report regarding VODG on April 27, 2012 (http://www.dailypennystocks.com/vodg-stem-cells-without-ethical-problems/ ). While the Company cannot be certain, it is a reasonable inference that this report resulted in significant and unusual trading volume and increased the stock price of VODG.
